FDA Medical Device Registration, Listing and Compliance Pathway Support

Support for FDA product-code and pathway identification, establishment registration, device listing, U.S. agent data and premarket-submission coordination based on intended use, classification and establishment activity.

Service overview

U.S. medical-device compliance begins with intended use and technology to determine device status, classification, product code and whether a premarket route such as 510(k), De Novo or PMA applies. Establishment registration and device listing are then assessed by establishment role. Registration and listing record establishments and devices; they are not FDA marketing approval and do not replace required premarket authorization.

Applicable products or businesses

• Medical-device manufacturers, specification developers, contract manufacturers, repackagers/relabelers and import-related establishments
• Devices requiring initial classification, product-code or premarket-pathway assessment
• Projects requiring initial/annual establishment registration, device listing or maintenance

Target market

• U.S. medical-device market

Regulatory authority

• FDA Center for Devices and Radiological Health or another applicable FDA center

Regulations, directives and standards

• Medical-device provisions of the FD&C Act and applicable 21 CFR Parts 800-898
• 21 CFR Part 807 establishment registration, listing and premarket-notification rules
• Classification-dependent 510(k), De Novo, PMA, quality-system, labelling and reporting requirements

Service scope

• Initial device definition, intended-use, classification and product-code screening
• Establishment-activity and registration/listing duty assessment
• U.S. agent, official correspondent and FURLS/DRLM data preparation
• Alignment with premarket submission numbers, labelling and quality-system status

Service process

• Collect intended use, indications, technology and user population
• Research classification regulations, product codes and predicate/device context
• Determine establishment roles and the premarket pathway
• Prepare registration, listing, U.S. agent and correspondent data
• Complete system submissions and establish annual update/change control

Information required

• Product description, intended use, indications and operating principle
• Risk class, product code and available premarket submission information
• Legal establishment name, address, FEI, activity type and owner/operator information
• U.S. agent and official correspondent details
• Labels, models, manufacturing relationships and quality-system information

## Reports, certificates or registration outcomes Outputs may include a classification/pathway memorandum and establishment-registration/device-listing submission support. Registration or listing does not mean FDA approval; devices requiring premarket authorization must complete the applicable process before lawful marketing.

Factors affecting timing

Timing depends on classification complexity, product-code confirmation, premarket submission status, fee/account readiness, FEI matching, U.S. agent confirmation and system feedback.

Common compliance risks

• Registering/listing before the device classification is understood
• Treating registration/listing as 510(k) clearance or PMA approval
• Confusing manufacturer, specification developer and contract-manufacturer roles
• FDA records are not updated after product or establishment changes

Related services

• FDA FEI information support
• Medical-device testing and technical documentation
• Medical-device labelling compliance
• Dual FDA laser/medical-device pathway assessment

Information for an initial assessment

Provide the product name, model, intended use, target market, bill of materials and available reports so that the applicable route and evidence gaps can be assessed.